Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
HT

Herriot Tabuteau

AI Antecip Bioventures Ii: 10 patents #1 of 1Top 100%
AT Axsome Therapeutics: 5 patents #1 of 1Top 100%
AM Axsome Malta: 1 patents #2 of 8Top 25%
📍 New York, NY: #8 of 2,453 inventorsTop 1%
🗺 New York: #52 of 9,062 inventorsTop 1%
Overall (2025): #2,403 of 469,880Top 1%
16
Patents 2025

Issued Patents 2025

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDate
12390428 Bupropion and dextromethorphan for reduction of suicide risk in depression patients 2025-08-19
12377091 Compounds and combinations thereof for treating neurological and psychiatric conditions 2025-08-05
12370154 Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan 2025-07-29
12370196 Pharmaceutical compositions comprising meloxicam 2025-07-29
12364674 Compounds and combinations thereof for treating neurological and psychiatric conditions 2025-07-22
12357640 Pharmaceutical compositions comprising meloxicam 2025-07-15
12357697 Pharmaceutical compositions comprising bupropion and cysteine 2025-07-15
12310961 Bupropion dosage forms with reduced food and alcohol dosing effects 2025-05-27
12268693 Pharmaceutical compositions comprising a tolfenamic acid 2025-04-08
12263145 Methods of administering solriamfetol to lactating women 2025-04-01
12263161 Bupropion dosage forms with reduced food and alcohol dosing effects 2025-04-01
12246023 Use of reboxetine to treat narcolepsy 2025-03-11
12239642 Bupropion dosage forms with reduced food and alcohol dosing effects 2025-03-04
12194006 Bupropion as a modulator of drug activity 2025-01-14
12194036 Combination of dextromethorphan and bupropion for treating depression 2025-01-14
12194005 Compounds and combinations thereof for treating neurological and psychiatric conditions 2025-01-14